ITEMS IN AFP WITH KEYWORD:
Dec 1, 2007 Issue
Patient-Controlled Analgesia for Postoperative Pain [Cochrane for Clinicians]
Patient-controlled opioid analgesia is safe and provides a statistically significant improvement in analgesia in postoperative patients, but the clinical significance of the improvement is marginal.
Oct 1, 2007 Issue
Opioid Analgesia During Evaluation of Acute Abdominal Pain [Cochrane for Clinicians]
Providing early opioid analgesia to patients presenting with acute abdominal pain does not affect or delay management decisions, but it lessens pain intensity as rated by the patient.
Tramadol is an effective treatment for neuropathic pain. One out of four patients who take the medication achieves at least 50 percent pain relief.
Although many patients with RLS do not need pharmacologic therapy, pramipexole is one option for treating moderate to severe symptoms. As with other agents used to manage RLS, potentially serious adverse reactions are possible.
Apr 1, 2007 Issue
Are Opioids Effective in the Treatment of Neuropathic Pain? [Cochrane for Clinicians]
Eight to 60 days of opioid therapy for the treatment of neuropathic pain effectively reduces pain scores as measured by a visual analog scale. A lack of response to opioids in the first 24 hours should not be used to predict whether longer-term opioid therapy might be beneficial. There are no contro...
Dec 1, 2006 Issue
Opioids for Management of Breakthrough Pain in Cancer Patients [Cochrane for Clinicians]
Oral transmucosal fentanyl citrate (OTFC [Actiq]), a rapid-acting opioid, has been shown to be an effective treatment for breakthrough cancer pain. Other opioids, including immediate-release oral morphine (MSIR), also may be effective; however, evidence comparing these agents with OTFC is lacking.
Opioid analgesics are useful agents for treating pain of various etiologies; however, adverse effects are potential limitations to their use. Strategies to minimize adverse effects of opioids include dose reduction, symptomatic management, opioid rotation, and changing the route of administration. N...
Jul 1, 2006 Issue
Systemic Lidocaine or Mexiletine for Neuropathic Pain [Cochrane for Clinicians]
Intravenous lidocaine and oral mexiletine provide a modest reduction in neuropathic pain with no indication of serious adverse effects. However, safety data are limited because most studies were of relatively short duration and fewer than 400 patients have been studied in total for each drug. Intrav...
Two small trials have shown carbamazepine to be beneficial in the treatment of diabetic neuropathic pain. Carbamazepine shows similar clinical effect to gabapentin (Neurontin) and phenytoin (Dilantin), but there have been no head-to-head trials directly comparing these drugs. Carbamazepine is effect...
At high dosages, gabapentin is moderately effective for neuropathic pain, although adverse effects are experienced as often as benefit.